AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Custom Antibody Market by Service, Type, Source, Research Area, and End Users - Global Forecast to 2023 - ResearchAndMarkets.com

January 3, 2019

DUBLIN--(BUSINESS WIRE)--Jan 3, 2019--The “Custom Antibody Market by Service (Antibody Production, Characterization, Immunization, Fragmentation), Type (Monoclonal, Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area (Oncology, Immunology), and End Users - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.

The custom antibody market is expected to reach USD 481 million by 2023 from an estimated USD 313 million in 2018, at a CAGR of 8.9%.

Increase in research activities (especially in the life sciences industry), growing industry-academia collaborations, and the expanding antibody therapeutics pipeline are the primary growth drivers for this market. Rapid growth in developing countries across APAC and Latin America and the increasing demand for personalized medicine and protein therapeutics are expected to offer significant growth opportunities for players in this market. However, the need for steep capital investments and long duration of antibody development, along with the increasing focus on antibody alternatives for proteomic studies, are some of the major market challenges.

On the basis of services, the custom antibody market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. The antibody production & purification segment is projected to witness the highest growth in the custom antibody services market during the forecast period. Growth in this segment is largely driven by the need for high-quality antibodies for research reproducibility and generating high-quality therapeutics.

Based on type, custom antibodies are categorized as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The recombinant antibodies segment is projected to witness the highest growth rate during the forecast period. The increasing development of recombinant antibodies due to their advantages such as batch-to-batch reproducibility, rapid production along with their capability of data reproducibility within research is propelling the growth of this segment during the forecast period.

Key Topics Covered:

1 Custom Antibody Market: Introduction

2 Custom Antibody Market: Research Methodology

3 Custom Antibody Market: Executive Summary

4 Custom Antibody Market: Premium Insights

5 Custom Antibody Market: Overview

6 Custom Antibody Market, By Service

7 Custom Antibody Market, By Type

8 Custom Antibody Market, By Source

9 Custom Antibody Market, By Research Area

10 Custom Antibody Market, By End User

11 Custom Antibody Market, By Region

12 Custom Antibody Market: Competitive Landscape

13 Company Profiles

Abcam PLC Agilent Technologies, Inc. Bio-Rad Laboratories, Inc. Biolegend, Inc. Cell Signaling Technology, Inc. Genscript Innovagen Ab Merck Group Promab Biotechnologies, Inc. Proteogenix Rockland Immunochemicals Inc. Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/wk2fxt/custom_antibody?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190103005502/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: OTHER SCIENCE SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/03/2019 11:24 AM/DISC: 01/03/2019 11:24 AM

http://www.businesswire.com/news/home/20190103005502/en